Annual Total Long Term Liabilities
$67.00 K
-$150.34 M-99.96%
December 31, 2023
Summary
- As of February 25, 2025, ELVN annual total long term liabilities is $67.00 thousand, with the most recent change of -$150.34 million (-99.96%) on December 31, 2023.
- During the last 3 years, ELVN annual total long term liabilities has fallen by -$149.76 million (-99.96%).
- ELVN annual total long term liabilities is now -99.96% below its all-time high of $150.46 million, reached on December 31, 2021.
Performance
ELVN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
-$6000.00-100.00%
September 30, 2024
Summary
- As of February 25, 2025, ELVN quarterly total long term liabilities is $0.00, with the most recent change of -$6000.00 (-100.00%) on September 30, 2024.
- Over the past year, ELVN quarterly long term liabilities has stayed the same.
- ELVN quarterly long term liabilities is now -100.00% below its all-time high of $150.56 million, reached on September 30, 2022.
Performance
ELVN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ELVN Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% |
ELVN Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low |
| alltime | all time | -100.0% | at low | -100.0% | at low |
Enliven Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $6000.00(-82.4%) |
| Mar 2024 | - | $34.00 K(-49.3%) |
| Dec 2023 | $67.00 K | $67.00 K(-68.7%) |
| Sep 2023 | - | $214.00 K(-40.6%) |
| Jun 2023 | - | $360.00 K(-29.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $508.00 K(-99.7%) |
| Dec 2022 | $150.41 M(-0.0%) | $150.41 M(-0.1%) |
| Sep 2022 | - | $150.56 M(+0.1%) |
| Dec 2021 | $150.46 M(+0.4%) | - |
| Dec 2021 | - | $150.46 M |
| Dec 2020 | $149.83 M | - |
FAQ
- What is Enliven Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Enliven Therapeutics?
- What is Enliven Therapeutics annual total long term liabilities year-on-year change?
- What is Enliven Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly long term liabilities year-on-year change?
What is Enliven Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ELVN is $67.00 K
What is the all time high annual total long term liabilities for Enliven Therapeutics?
Enliven Therapeutics all-time high annual total long term liabilities is $150.46 M
What is Enliven Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ELVN annual total long term liabilities has changed by -$150.34 M (-99.96%)
What is Enliven Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ELVN is $0.00
What is the all time high quarterly long term liabilities for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly total long term liabilities is $150.56 M
What is Enliven Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ELVN quarterly total long term liabilities has changed by $0.00 (0.00%)